---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-003301"
form_type: "8-K"
ticker: "ZEOX"
cik: "0001557376"
company_name: "Zeo ScientifiX, Inc."
filed_at: "2026-04-09T23:59:59+00:00"
generated_at: "2026-05-15T06:47:16.768315+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "medium"
source: SEC EDGAR
---

# ZEO signs MOU to be exclusive biologics supplier for Regen Therapy's 3,000-clinic network

## Summary
- MOU positions ZEO as core supplier of advanced biologic therapeutics for Regen Therapy's regenerative platform.
- Regen Therapy's network includes over 3,000 clinics and 24,000 practitioners across the U.S.
- Regen also partnered with Stealth Health for white-label telemedicine and longevity services.
- No financial terms or binding agreement disclosed; MOU is non-definitive.
- ZEO's expertise in extracellular vesicle and perinatal-derived therapeutics to support next-gen products.

## SEC filing metadata
- accession: 0001829126-26-003301
- form_type: 8-K
- ticker: ZEOX
- cik: 0001557376
- company_name: Zeo ScientifiX, Inc.
- filed_at: 2026-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557376/000182912626003301/0001829126-26-003301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557376/000182912626003301/zeoscientifix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-003301
- JSON: https://secwatch.observer/filing/0001829126-26-003301.json
- Plain text: https://secwatch.observer/filing/0001829126-26-003301.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.